Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

about

Management of Elderly Patients with Glioblastoma.Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model

P2860

Q39190627-BA3FA9AF-29BD-4CFE-BE1B-843501502F5C Q58586901-23912ED4-81F4-4593-A5E1-C01763B86DFA

P2860

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

Item

http://www.wikidata.org/entity/Q38800041

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

@en

type

Item

label

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

@en

prefLabel

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

@en

P1476

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

@en

P2093

Dorothee Gramatzki

http://www.w3.org/2001/XMLSchema#string

Katharina Seystahl

http://www.w3.org/2001/XMLSchema#string

Patrick Roth

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

MGMT gene silencing and benefit from temozolomide in glioblastoma.

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

The somatic genomic landscape of glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

A randomized trial of bevacizumab for newly diagnosed glioblastoma

P304

1259-1270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1176146

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Weller

P577

2016-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27052640

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

about

P2860

P2860

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921